Schott Pharma AG & CO KGaA annual current ratio
2020
2021
2022
2023
2024
2025
Schott Pharma AG & CO KGaA Current Ratio Growth & History (1SXP)
Schott Pharma AG & CO KGaA's current ratio was 1.50 for fiscal 2025.
View full Schott Pharma AG & CO KGaA company overviewSchott Pharma AG & CO KGaA annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-30 | 1.50 | 0.16 | +11.91% |
| 2024 | 2024-09-30 | 1.34 | 0.01 | +0.59% |
| 2023 | 2023-09-30 | 1.33 | −0.38 | −22.31% |
| 2022 | 2022-09-30 | 1.72 | 0.48 | +38.74% |
| 2021 | 2021-09-30 | 1.24 | 0.10 | +8.65% |
| 2020 | 2020-09-30 | 1.14 | — | — |
Schott Pharma AG & CO KGaA quarterly current ratio
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-30 | 1.61 | 0.04 | +2.25% |
| Q2 2026 | 2026-03-31 | 1.59 | 0.16 | +11.02% |
| Q1 2026 | 2025-12-31 | 1.58 | — | — |
| Q4 2025 | 2025-09-30 | 1.50 | — | — |
| Q3 2025 | 2025-06-30 | 1.57 | — | — |
| Q2 2025 | 2025-03-31 | 1.43 | — | — |
Schott Pharma AG & CO KGaA current ratio trends
Over the last five fiscal years, Schott Pharma AG & CO KGaA's current ratio increased from 1.14 to 1.50, a change of 0.36. The latest reported quarter, Q3 2026, shows 1.61.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as reported current assets divided by reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Schott Pharma AG & CO KGaA source filings ↗